Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
BTAI on Nasdaq
Frank Yocca - trading volume in the past year for BioXcel Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
1.87K |
$660 |
$0.35 |
Mar 15, 2025 |
Direct |
|
|
| Restricted Stock Units |
387 |
$136 |
$0.35 |
Mar 15, 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
270K |
|
|
Jan 7, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.